Alamar Biosciences, Inc. (ALMR) vs Liquidia Corporation (LQDA)

A side-by-side comparison of Alamar Biosciences, Inc. and Liquidia Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alamar Biosciences, Inc. logo
ALMR
Alamar Biosciences, Inc.
$2.44B
$35.21HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
Liquidia Corporation logo
LQDA
Liquidia Corporation
$2.39B
$26.86HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT

Total return — ALMR vs LQDA

growth of $100 · dividends reinvested · last 1y
ALMR +73.3% (+73.3%/yr)LQDA -30.0% (-30.0%/yr)ALMR compounded faster over this window
100150200Start $100$173$70
ALMR LQDA

ALMR vs LQDA: by the numbers

  • •ALMR is the larger company ($2.44B vs $2.39B market cap).
  • •LQDA is profitable (30.74% net margin) while ALMR runs a net loss (-40.18%).

Metrics side by side

Valuation

MetricALMRLQDA
P/E ratioN/A19.62
Forward P/EN/A10.81
P/S ratioN/A5.30
P/B ratio7.8012.24
EV / EBITDAN/A13.12
FCF yieldN/A2.53%

Profitability

MetricALMRLQDA
Gross margin56.20%92.48%
Operating margin-42.22%-32.45%
Net margin-40.18%30.74%
ROEN/A71.04%
ROIC-26.95%46.99%

Growth (annualized)

MetricALMRLQDA
Revenue CAGR (5Y)N/A128.77%
Total return CAGR (5Y)N/A59.01%

Frequently asked

Is ALMR or LQDA more profitable?
LQDA runs the higher net margin — ALMR at -40.18% versus LQDA at 30.74%.

Go deeper

Full ALMR analysisFull LQDA analysisInteractive comparison tool

Dig into the metrics

Liquidia P/E ratioAlamar Biosciences ROELiquidia ROEAlamar Biosciences operating marginLiquidia operating marginAlamar Biosciences revenue growthLiquidia revenue growthAlamar Biosciences free cash flowLiquidia free cash flow

Alamar Biosciences & Liquidia appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.